Stay updated on Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says that “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-26T14:50:55.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site footer revision label changes from v3.7.1 to v3.7.2; the study record page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T14:38:11.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T15:34:48.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    A 403 Forbidden page now displays for the study record, indicating access is blocked. A large portion of the trial's core metadata and related terms appears to have been removed, reducing the information available to readers.
    Difference
    18%
    Check dated 2026-09-21T22:01:03.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.6.6 is added, replacing v3.6.5, which indicates a site version update with no visible changes to the study details.
    Difference
    0.1%
    Check dated 2026-08-31T17:24:04.000Z thumbnail image
  6. Check
    83 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.5, replacing the previous v3.6.4, indicating a new version of the page content. This maintenance update does not change study information or user-facing content.
    Difference
    0.1%
    Check dated 2026-08-10T12:32:20.000Z thumbnail image

Stay in the know with updates to Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial page.